On Thursday, Shares of Allergan plc Ordinary Shares (NYSE:AGN), added 0.47% and now trading at $238.89 in the current trading session. The current trading range of the stock ranges between $237.15 and $239.97
llergan plc (NYSE: AGN), a leading global biopharmaceutical company, and ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, recently declared that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”) has expired with respect to Allergan’s projected acquisition of ZELTIQ.
On February 13, 2017, Allergan and ZELTIQ reached a definitive agreement under which Allergan has agreed to acquire ZELTIQ. Following the declarement of the transaction, each of Allergan and ZELTIQ filed a Notification and Report Form following the HSR Act with the Antitrust Division of the U.S. Department of Justice and the Federal Trade Commission.
Expiration of the waiting period under the HSR Act satisfies one of the conditions to the closing of the pending acquisition, which remains subject to other customary closing conditions, counting approval by the stockholders of ZELTIQ.
ZELTIQ is planned to hold a stockholder meeting on April 27, 2017 to vote on the projected transaction, and the companies expect the transaction to be accomplished shortly thereafter.
Analyst recommendation for this stock stands at 2.00.